[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-542047-105":59,"doc-detail-542047-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","contributors-relationship-disclosures-and-unlabeled-use-statements","CONTRIBUTORS - Relationship Disclosures and Unlabeled Use Statements","","Contributors section listing medical editors and authors with institutional affiliations and detailed relationship disclosure statements. Includes multiple disclosures of publishing royalties, editorial and advisory board compensation ranges, and research support sources. Also provides unlabeled or investigational use disclosures for various neurological treatments, specifying that certain medications and interventions are discussed for conditions such as Parkinson disease, Tourette syndrome, and related tic or movement disorders. A statement indicates that relevant financial relationships have been mitigated and includes copyright and reproduction restrictions for 2025.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/contributors-relationship-disclosures-and-unlabeled-use-statements/542047/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/contributors-relationship-disclosures-and-unlabeled-use-statements/542047.png","ImageObject",300,407,{"name":92,"@type":93},"Aria Callaghan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-10-10",true,{"@type":102,"interactionType":103,"userInteractionCount":14},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What information does the Contributors section provide?","Question",{"text":112,"@type":113},"It provides names of contributors (editors/authors), their affiliations, and detailed relationship disclosure statements.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What do the document’s “Unlabeled Use of Products/Investigational Use Disclosure” notes cover?",{"text":117,"@type":113},"They describe investigational or unlabeled uses of specific products and interventions discussed for treatment of neurological conditions.",{"name":119,"@type":110,"acceptedAnswer":120},"How are financial relationships addressed in the document?",{"text":121,"@type":113},"A note states that all relevant financial relationships have been mitigated, and the document includes copyright and unauthorized reproduction restrictions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},542047,1792671280,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":14,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","CONTRIBUTORSa  \nDownloaded from [https://continuum.aan.com by 2404:7a80:24c0:5500:c928:3ff0:2bd4:580c on 9 October 2026](https://continuum.aan.com by 2404:7a80:24c0:5500:c928:3ff0:2bd4:580c on 9 October 2026)  \nMichaelS. Okun, MD, FAAN, Guest Editor  \nDirector, Norman Fixel Institute for Neurological Diseases, Distinguished Professor of Neurology, University of Florida, Gainesville, Florida  \nRelationship Disclosure: Dr Okun has received publishing royalties from a publication relating to health care; personal compensation in the range of $0 to $499 for serving on a scientific advisory or data safety monitoring board for the National Institutes of Health (NIH); in the range of $500 to $4999 for serving as an editor, associate editor, or editorial advisory board member for NEJM Watch; in the range of $5000 to $9999 for serving as an editor, associate editor, or editorial advisory board member for JAMA Neurology; and in the range of $10,000 to $49,999 for serving as an officer or member of the board of directors for the Parkinson’s Foundation. The institution of Dr Okun has received research support from the Michael J. Fox Foundation for Parkinson’s Research, the NIH, the Parkinson’s Foundation, and the Tourette Association of America.  \nUnlabeled Use of Products/Investigational Use Disclosure: Dr Okun discusses the unlabeled/investigational use of donepeziland galantamine for the treatment of Parkinson disease.  \nAlan Carson, MD, MPhil, FRCPsych, FRCP  \nConsultant Neuropsychiatrist and Honorary Professor, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom  \nRelationship Disclosure: Dr Carson has noncompensated relationships as Immediate Past President of the Functional Neurological Disorder Society and Past President of the British Neuropsychiatry Association; has received personal compensation in the range of $10,000 to $49,999 for serving as an editor, associate editor, or editorial advisory board member for the Journal of Neurology, Neurosurgery and Psychiatry; and in the range of $100,000 to $499,999 for serving as an expert witness. Dr Carson has received research support from the Medical Research Council, European Union, Chief Scientific Officer Scotland, and UK research and innovation.  \nUnlabeled Use of Products/Investigational Use Disclosure: Dr Carson reports no disclosure.  \na All relevant financial relationships have been mitigated.  \n920 AUGUST 2 0 25  \nCopyright © 2025 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.  \nDownloaded from [https://continuum.aan.com by 2404:7a80:24c0:5500:c928:3ff0:2bd4:580c on 9 October 2026](https://continuum.aan.com by 2404:7a80:24c0:5500:c928:3ff0:2bd4:580c on 9 October 2026)  \nJessica Frey, MD  \nAssistant Professor of Neurology, Movement Disorders Fellowship Program Director, Neurology Student Clerkship Director, Rockefeller Neuroscience Institute, Department of Neurology, West Virginia University, Morgantown,  \nWest Virginia  \nRelationship Disclosure: Dr Frey has received research support from the Tourette Association of America.  \nUnlabeled Use of Products/Investigational Use Disclosure: Dr Frey discusses the unlabeled use of 5-Ling granule, acupuncture, amisulpride, atomoxetine, AZD5213, baclofen, biofeedback, botulinum toxin injections, cannabidiol, chiropractic manipulation, Choudongning capsule, clonidine, coenzyme Q10, cognitive behavioral therapy, comprehensive behavioral intervention for tics, cranial electrotherapy, D-cycloserine, deep brain stimulation, deutetrabenazine, direct current stimulation, dronabinol, ecopipam, exposure and response prevention,fish oil, fluphenazine, guanfacine, habit reversal therapy, hypnosis, levetiracetam, Lu-AG06466, median nerve stimulation, methylphenidate, nabiximol, Ningdong granule, olanzapine, oral splints, palmitoylethanolamide, pimavanserin, PS128, quetiapine, repetitive transcranial magnetic stimulation, risperidone, sodium valproate, sulpiride, taurine, tetrabena","cbCaicobJFRTXL5K","https://ap.wps.com/l/cbCaicobJFRTXL5K","pdf",1379413,"English","# Contributors\n## Relationship Disclosure\n## Unlabeled Use of Products/Investigational Use Disclosure\n## Copyright Notice","[{\"question\":\"What information does the Contributors section provide?\",\"answer\":\"It provides names of contributors (editors/authors), their affiliations, and detailed relationship disclosure statements.\"},{\"question\":\"What do the document’s “Unlabeled Use of Products/Investigational Use Disclosure” notes cover?\",\"answer\":\"They describe investigational or unlabeled uses of specific products and interventions discussed for treatment of neurological conditions.\"},{\"question\":\"How are financial relationships addressed in the document?\",\"answer\":\"A note states that all relevant financial relationships have been mitigated, and the document includes copyright and unauthorized reproduction restrictions.\"}]","CONTRIBUTORS - Relationship Disclosures and Unlabeled Use Statements | PDF",1791669152]